Nektar Therapeutics (Nasdaq: NKTR) shares have tumbled more than 4% today on the heels of an earlier downgrade from an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE